Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
PetIQ 'a smart way' to play pet care boom, Barron's says » 10:48
04/17/21
04/17
10:48
04/17/21
10:48
PETQ

PetIQ

$37.06 /

+0.43 (+1.17%)

, CHWY

Chewy

$84.15 /

-2.435 (-2.81%)

, FRPT

Freshpet

$172.13 /

+1.63 (+0.96%)

, IDXX

Idexx Laboratories

$535.29 /

+7.12 (+1.35%)

, ZTS

Zoetis

$167.59 /

+2.08 (+1.26%)

Pet-supply sales are…

Pet-supply sales are going strong as pet owners buy everything from kibble infused with quinoa and avocado to hip-and-joint supplements to prevent arthritis, Daren Fonda writes in this week's edition of Barron's. PetIQ (PETQ) is flourishing in this climate, and its stock looks like one of the few bargains in the sector, the author notes. The company manufactures and distributes pet-health products and operates veterinary clinics around the country. At recent prices around $36, the stock trades for 19 times estimated 2022 earnings. That's far cheaper than larger companies in the booming pet sector, including Chewy (CHWY), FreshPet (FRPT), Idexx Laboratories (IDXX), and Zoetis (ZTS), the publication adds. Reference Link

ShowHide Related Items >><<
ZTS Zoetis
$167.59 /

+2.08 (+1.26%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

10/15/20 Jefferies
PetIQ assumed with a Buy at Jefferies
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
07/01/20 Raymond James
PetIQ price target raised to $41 from $35 at Raymond James
06/25/20 Guggenheim
PetIQ price target raised to $44 from $33.50 at Guggenheim
CHWY Chewy
$84.15 /

-2.435 (-2.81%)

04/05/21 Evercore ISI
Chewy assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Chewy initiated with a Peer Perform at Wolfe Research
03/31/21 Wedbush
Chewy price target raised to $100 from $90 at Wedbush
03/31/21 Jefferies
Chewy price target raised to $105 from $100 at Jefferies
FRPT Freshpet
$172.13 /

+1.63 (+0.96%)

03/11/21 DA Davidson
Freshpet price target raised to $217 from $194 at DA Davidson
02/25/21 Truist
Freshpet price target raised to $150 from $140 at Truist
02/25/21 Citi
Freshpet price target raised to $123 from $100 at Citi
02/24/21 DA Davidson
Freshpet price target raised to $194 from $172 at DA Davidson
IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
ZTS Zoetis
$167.59 /

+2.08 (+1.26%)

03/09/21 Stifel
Zoetis 'oversold,' among 'best long-term ideas,' says Stifel
03/08/21 Raymond James
Zoetis upgraded to Outperform from Market Perform at Raymond James
03/08/21 Raymond James
Zoetis upgraded to Outperform from Market Perform at Raymond James
03/08/21 BofA
Zoetis upgraded to Buy from Neutral at BofA
ZTS Zoetis
$167.59 /

+2.08 (+1.26%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

FRPT Freshpet
$172.13 /

+1.63 (+0.96%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

  • 13
    Apr
  • 20
    Apr
  • 12
    Mar
  • 24
    Feb
  • 17
    Sep
CHWY Chewy
$84.15 /

-2.435 (-2.81%)

FRPT Freshpet
$172.13 /

+1.63 (+0.96%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

Yesterday
Hot Stocks
FDA revokes emergency use authorization for Eli Lilly's bamlanivimab » 16:46
04/16/21
04/16
16:46
04/16/21
16:46
LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

The U.S. FDA revoked the…

The U.S. FDA revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has determined that the known and potential benefits of bamlanivimab, when administered alone, no longer outweigh the known and potential risks for its authorized use. Therefore, the agency determined that the criteria for issuance of an authorization are no longer met and has revoked the EUA. Reference Link

ShowHide Related Items >><<
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:29
04/16/21
04/16
16:29
04/16/21
16:29
MS

Morgan Stanley

$78.58 /

-2.31 (-2.86%)

, BK

BNY Mellon

$46.05 /

-1.97 (-4.10%)

, CFG

Citizens Financial

$44.82 /

+0.15 (+0.34%)

, STT

State Street

$80.46 /

-6.07 (-7.01%)

, C

Citi

$72.46 /

-0.07 (-0.10%)

, ALXN

Alexion

$163.62 /

+6.19 (+3.93%)

, AZN

AstraZeneca

$50.74 /

-0.1 (-0.20%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

, BA

Boeing

$248.11 /

-3.09 (-1.23%)

, SQSP

Squarespace

/

+

, LSCC

Lattice Semiconductor

$57.90 /

+6.77 (+13.24%)

, PPG

PPG

$167.43 /

+13.57 (+8.82%)

, AA

Alcoa

$35.63 /

+2.765 (+8.41%)

, EDIT

Editas Medicine

$34.63 /

-6.28 (-15.35%)

, SPLK

Splunk

$134.31 /

-14.09 (-9.49%)

, MRNA

Moderna

$170.77 /

+10.95 (+6.85%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

The major averages closed…

ShowHide Related Items >><<
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

04/16/21 Wells Fargo
Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss
04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

04/09/21 Deutsche Bank
BNY Mellon price target raised to $54 from $50 at Deutsche Bank
04/07/21 Barclays
BNY Mellon price target raised to $57 from $55 at Barclays
03/26/21 JPMorgan
JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
03/24/21
Fly Intel: Top five analyst upgrades
CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

04/09/21 Jefferies
Citizens Financial price target raised to $47 from $42 at Jefferies
04/07/21 Barclays
Citizens Financial price target raised to $54 from $49 at Barclays
04/01/21 Deutsche Bank
Citizens Financial price target raised to $50 from $44 at Deutsche Bank
03/30/21 Stephens
Citizens Financial price target raised to $54 from $45 at Stephens
STT State Street
$80.46 /

-6.07 (-7.01%)

04/09/21 Deutsche Bank
State Street price target raised to $100 from $97 at Deutsche Bank
04/07/21 Barclays
State Street price target raised to $104 from $99 at Barclays
04/01/21 Wells Fargo
State Street price target raised to $90 from $83 at Wells Fargo
04/01/21 Morgan Stanley
State Street price target raised to $103 from $102 at Morgan Stanley
C Citi
$72.46 /

-0.07 (-0.10%)

04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
ALXN Alexion
$163.62 /

+6.19 (+3.93%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
Alexion downgraded to Market Perform from Outperform at SVB Leerink
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
BA Boeing
$248.11 /

-3.09 (-1.23%)

04/15/21 Credit Suisse
Boeing price target raised to $233 from $193 at Credit Suisse
04/14/21 JPMorgan
Boeing price target raised to $260 from $230 at JPMorgan
04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
SQSP Squarespace
/

+

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

02/17/21 Craig-Hallum
Lattice Semiconductor price target raised to $40 from $31 at Craig-Hallum
02/17/21 KeyBanc
Lattice Semiconductor price target raised to $57 from $50 at KeyBanc
02/17/21 Cowen
Lattice Semiconductor price target raised to $56 from $48 at Cowen
02/17/21 Susquehanna
Lattice Semiconductor price target raised to $56 from $52 at Susquehanna
PPG PPG
$167.43 /

+13.57 (+8.82%)

04/15/21 Citi
Citi opens '30-day negative catalyst watch' on Axalta, PPG
04/07/21 Wells Fargo
PPG price target raised to $173 from $165 at Wells Fargo
03/15/21 Credit Suisse
PPG assumed with a Neutral at Credit Suisse
01/26/21 BofA
PPG upgraded to Buy from Neutral at BofA
AA Alcoa
$35.63 /

+2.765 (+8.41%)

04/16/21 B. Riley
Alcoa price target raised to $36 from $20 at B. Riley
04/16/21 BMO Capital
Alcoa price target raised to $38 from $36 at BMO Capital
03/24/21 Morgan Stanley
Morgan Stanley upgrades Alcoa to Overweight on better prospects for aluminum
EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

04/16/21
Fly Intel: Top five analyst initiations
04/16/21 Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
SPLK Splunk
$134.31 /

-14.09 (-9.49%)

04/16/21
Fly Intel: Top five analyst downgrades
04/16/21 KeyBanc
Splunk downgraded to Sector Weight from Overweight at KeyBanc
04/08/21 BofA
Splunk reinstated with a Buy at BofA
04/08/21 BofA
Splunk reinstated with a Buy at BofA
MRNA Moderna
$170.77 /

+10.95 (+6.85%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

  • 21
    Jan
  • 24
    Jun
  • 19
    May
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

Conference/Events
Amyris to host conference call » 16:24
04/16/21
04/16
16:24
04/16/21
16:24
AMRS

Amyris

$15.05 /

-0.66 (-4.20%)

Management holds an…

Management holds an investor update conference call on April 22 at 1 pm. Webcast Link

ShowHide Related Items >><<
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

AMRS Amyris
$15.05 /

-0.66 (-4.20%)

03/03/21 Roth Capital
Amyris price target raised to $33 from $20 at Roth Capital
03/03/21 H.C. Wainwright
Amyris price target raised to $35 from $11 at H.C. Wainwright
02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

  • 09
    Apr
AMRS Amyris
$15.05 /

-0.66 (-4.20%)

AMRS Amyris
$15.05 /

-0.66 (-4.20%)

Conference/Events
Roche to host sales conference call » 16:16
04/16/21
04/16
16:16
04/16/21
16:16
RHHBY

Roche

$42.11 /

+0.26 (+0.62%)

Conference call to…

Conference call to discuss 1Q21 sales will be held on April 21 at 8 am. Webcast Link

ShowHide Related Items >><<
RHHBY Roche
$42.11 /

+0.26 (+0.62%)

RHHBY Roche
$42.11 /

+0.26 (+0.62%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
RHHBY Roche
$42.11 /

+0.26 (+0.62%)

RHHBY Roche
$42.11 /

+0.26 (+0.62%)

RHHBY Roche
$42.11 /

+0.26 (+0.62%)

Conference/Events
Marinus Pharmaceuticals management to meet virtually with Evercore » 15:44
04/16/21
04/16
15:44
04/16/21
15:44
MRNS

Marinus Pharmaceuticals

$14.11 /

-0.28 (-1.95%)

Virtual Meeting to be…

Virtual Meeting to be held on April 20 hosted by Evercore.

ShowHide Related Items >><<
MRNS Marinus Pharmaceuticals
$14.11 /

-0.28 (-1.95%)

MRNS Marinus Pharmaceuticals
$14.11 /

-0.28 (-1.95%)

03/10/21 H.C. Wainwright
Marinus Pharmaceuticals price target raised to $38 from $35 at H.C. Wainwright
11/10/20 Cantor Fitzgerald
Marinus Pharmaceuticals price target raised to $27 from $8 at Cantor Fitzgerald
09/30/20 Truist
Marinus Pharmaceuticals initiated with a Buy at Truist
09/25/20 JMP Securities
Marinus Pharmaceuticals price target raised to $26 from $7 at JMP Securities
MRNS Marinus Pharmaceuticals
$14.11 /

-0.28 (-1.95%)

  • 08
    Dec
  • 29
    May
MRNS Marinus Pharmaceuticals
$14.11 /

-0.28 (-1.95%)

Hot Stocks
J&J sees no 'causal relationship' between Covid vaccine and blood clots » 14:25
04/16/21
04/16
14:25
04/16/21
14:25
JNJ

Johnson & Johnson

$162.09 /

+1.59 (+0.99%)

Three Johnson &…

Three Johnson & Johnson employees involved in vaccine development and epidemiology told the New England Journal of Medicine, "At this time, evidence is insufficient to establish a causal relationship between these events and the Ad26.COV2.S vaccine." Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.09 /

+1.59 (+0.99%)

JNJ Johnson & Johnson
$162.09 /

+1.59 (+0.99%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$162.09 /

+1.59 (+0.99%)

JNJ Johnson & Johnson
$162.09 /

+1.59 (+0.99%)

JNJ Johnson & Johnson
$162.09 /

+1.59 (+0.99%)

JNJ Johnson & Johnson
$162.09 /

+1.59 (+0.99%)

Periodicals
Canada secures 8M additional Pfizer COVID-19 vaccine doses, CTV News says » 13:57
04/16/21
04/16
13:57
04/16/21
13:57
PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, BNTX

BioNTech

$147.00 /

+6.36 (+4.52%)

, MRNA

Moderna

$169.28 /

+9.46 (+5.92%)

Canadian Prime Minister…

Canadian Prime Minister Justin Trudeau said that the country's federal government has secured 8M more doses of the COVID-19 vaccine from Pfizer (PFE) and BioNTech (BNTX), hwich will come over the next few months, CTV News' Rachel Aiello reports. The news comes as Moderna (MRNA) revealed that its April vaccine shipment to Canada will be smaller than previously promised, Aiello says. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$169.28 /

+9.46 (+5.92%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MRNA Moderna
$169.28 /

+9.46 (+5.92%)

BNTX BioNTech
$147.00 /

+6.36 (+4.52%)

Hot Stocks
Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer » 13:13
04/16/21
04/16
13:13
04/16/21
13:13
BMY

Bristol-Myers

$65.21 /

+0.77 (+1.19%)

Bristol Myers Squibb…

Bristol Myers Squibb announced that Opdivo, in combination with fluoropyrimidine- and platinum-containing chemotherapy, was approved by the U.S. Food and Drug Administration for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, regardless of PD-L1 expression status. Opdivo is associated with the following Warnings and Precautions: severe and fatal immune-mediated adverse reactions including pneumonitis, colitis, hepatitis and hepatotoxicity, endocrinopathies, nephritis and renal dysfunction, dermatologic adverse reactions, other immune-mediated adverse reactions; infusion-related reactions; complications of allogeneic hematopoietic stem cell transplantation; embryo-fetal toxicity; and increased mortality in patients with multiple myeloma when Opdivo is added to a thalidomide analogue and dexamethasone, which is not recommended outside of controlled clinical trials. "We are focused on bringing transformative medicines to patients in need, and historically, there has been little progress for patients diagnosed with these metastatic gastroesophageal adenocarcinomas. As demonstrated in the CheckMate -649 trial, Opdivo is the first and only immunotherapy combined with chemotherapy to deliver superior overall survival versus chemotherapy alone in first-line metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma," said Adam Lenkowsky, general manager and head, U.S., Oncology, Immunology, Cardiovascular, Bristol Myers Squibb.

ShowHide Related Items >><<
BMY Bristol-Myers
$65.21 /

+0.77 (+1.19%)

BMY Bristol-Myers
$65.21 /

+0.77 (+1.19%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BMY Bristol-Myers
$65.21 /

+0.77 (+1.19%)

BMY Bristol-Myers
$65.21 /

+0.77 (+1.19%)

BMY Bristol-Myers
$65.21 /

+0.77 (+1.19%)

BMY Bristol-Myers
$65.21 /

+0.77 (+1.19%)

Hot Stocks
U.S. exceeds 200M COVID-19 vaccine doses administered » 12:36
04/16/21
04/16
12:36
04/16/21
12:36
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$416.72 /

+0.9 (+0.22%)

, PFE

Pfizer

$38.45 /

+0.84 (+2.23%)

, BNTX

BioNTech

$151.80 /

+11.16 (+7.94%)

, MRNA

Moderna

$171.20 /

+11.38 (+7.12%)

, JNJ

Johnson & Johnson

$161.69 /

+1.19 (+0.74%)

White House COVID-19 data…

White House COVID-19 data director Cyrus Shahpar said on Twitter that 3.97M more COVID-19 vaccine doses have been administered over yesterday's total at a rate that is "steady" with the prior two Fridays. "Overall a great day as we head toward 100% of states with universal eligibility for 16 and over, by Monday," Shahpar said. The Fly notes that the added administrations brings the U.S. to over 200M total vaccine shots administered. The U.S. has so far approved COVID-19 vaccines from Pfizer (PFE) and BioNTech (BNTX), and Moderna (MRNA), while the administration of Johnson & Johnson's (JNJ) vaccine has been paused amid blood clotting concerns. Reference Link

ShowHide Related Items >><<
SPX S&P 500
/

+

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$171.20 /

+11.38 (+7.12%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
SPX S&P 500
/

+

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

  • 23
    Jul
  • 19
    May
SPX S&P 500
/

+

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

SPX S&P 500
/

+

PFE Pfizer
$38.45 /

+0.84 (+2.23%)

MRNA Moderna
$171.20 /

+11.38 (+7.12%)

JNJ Johnson & Johnson
$161.69 /

+1.19 (+0.74%)

BNTX BioNTech
$151.80 /

+11.16 (+7.94%)

SPY SPDR S&P 500 ETF Trust
$416.72 /

+0.9 (+0.22%)

SPX S&P 500
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.